JP2021503483A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021503483A5 JP2021503483A5 JP2020527807A JP2020527807A JP2021503483A5 JP 2021503483 A5 JP2021503483 A5 JP 2021503483A5 JP 2020527807 A JP2020527807 A JP 2020527807A JP 2020527807 A JP2020527807 A JP 2020527807A JP 2021503483 A5 JP2021503483 A5 JP 2021503483A5
- Authority
- JP
- Japan
- Prior art keywords
- bone loss
- disease
- osteoporosis
- composition according
- functional food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010065687 Bone loss Diseases 0.000 claims 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 10
- 208000001132 Osteoporosis Diseases 0.000 claims 6
- 210000002307 prostate Anatomy 0.000 claims 6
- 235000013376 functional food Nutrition 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 208000002679 Alveolar Bone Loss Diseases 0.000 claims 3
- 208000013725 Chronic Kidney Disease-Mineral and Bone disease Diseases 0.000 claims 3
- 208000010191 Osteitis Deformans Diseases 0.000 claims 3
- 208000027868 Paget disease Diseases 0.000 claims 3
- 230000006378 damage Effects 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 239000005556 hormone Substances 0.000 claims 3
- 229940088597 hormone Drugs 0.000 claims 3
- 208000027202 mammary Paget disease Diseases 0.000 claims 3
- 210000000963 osteoblast Anatomy 0.000 claims 3
- 208000005368 osteomalacia Diseases 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 201000006409 renal osteodystrophy Diseases 0.000 claims 3
- 230000001629 suppression Effects 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 1
- 235000013861 fat-free Nutrition 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2017-0154820 | 2017-11-20 | ||
| KR20170154820 | 2017-11-20 | ||
| PCT/KR2018/014275 WO2019098811A2 (ko) | 2017-11-20 | 2018-11-20 | Chp(시클로-히스프로)를 포함하는 골 손실 질환의 예방, 개선 또는 치료용 조성물 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021503483A JP2021503483A (ja) | 2021-02-12 |
| JP2021503483A5 true JP2021503483A5 (enExample) | 2021-03-25 |
| JP6944221B2 JP6944221B2 (ja) | 2021-10-06 |
Family
ID=66538798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020527807A Active JP6944221B2 (ja) | 2017-11-20 | 2018-11-20 | Ｃｈｐ（シクロ−ヒスプロ）を含む骨損失疾患の予防、改善または治療用組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11975041B2 (enExample) |
| EP (1) | EP3714885B1 (enExample) |
| JP (1) | JP6944221B2 (enExample) |
| KR (1) | KR102163445B1 (enExample) |
| CN (1) | CN111372586B (enExample) |
| WO (1) | WO2019098811A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102115353B1 (ko) * | 2019-05-17 | 2020-05-26 | 주식회사 노브메타파마 | Chp(사이클로-히스프로) 및 부갑상선 호르몬을 포함하는 골 손실 질환의 예방, 개선 또는 치료용 조성물 |
| EP4199949A4 (en) * | 2020-08-20 | 2024-10-16 | NovMetaPharma Co., Ltd. | METHOD OF TREATMENT OF INFLAMMATORY ABDOMINAL CONDITIONS |
| KR102575908B1 (ko) * | 2020-12-11 | 2023-09-07 | 전남대학교산학협력단 | 락토바실러스 사케이 배양액 유래 사이클로디펩티드계 화합물의 분리방법 및 이를 포함하는 골 질환 예방 또는 치료용 조성물 |
| KR20250093685A (ko) | 2023-12-15 | 2025-06-25 | 주식회사 노브메타파마 | 사이클로-히스프로(chp)를 포함하는 운동수행능력 향상, 근 기능 개선 또는 근육 질환 예방, 개선 또는 치료용 조성물 |
| WO2025230339A1 (ko) * | 2024-04-30 | 2025-11-06 | 주식회사 노브메타파마 | 비만 치료제에 의한 근 소실 억제 또는 근 기능 저하 개선을 위한 사이클로-히스프로 단독 또는 아연 및 사이클로-히스프로의 용도 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2227658A (en) * | 1989-02-03 | 1990-08-08 | Cellana | Thyrotropin releasing hormone (trh) composition for enhancing immune function |
| US5418218A (en) * | 1992-07-10 | 1995-05-23 | The University Of Maryland At Baltimore | Histidyl-proline diketopiperazine (cyclo his-pro) a cns-active pharmacologic agent |
| DE4237456A1 (de) * | 1992-11-06 | 1994-05-11 | Merck Patent Gmbh | Cyclopeptide |
| US5834032A (en) * | 1997-08-11 | 1998-11-10 | Song; Moon K. | Compositions and methods for treating diabetes |
| AU6407099A (en) * | 1998-10-02 | 2000-04-26 | Celtrix Pharmaceuticals, Inc. | Methods for the treatment of non-thyroid disorders |
| MXPA02001882A (es) | 1999-08-23 | 2002-08-20 | Univ Tulane | Modulacion del transportador de leptina a traves de la barrera hemato-encefalica. |
| CA2446929C (en) | 2001-06-01 | 2013-04-09 | Novartis Ag | Orally administering parathyroid hormone and calcitonin |
| EP1643978A1 (en) | 2003-07-04 | 2006-04-12 | Nycomed Danmark A/S | Parathyroid hormone (pth) containing pharmaceutical compositions for oral use |
| CN100509008C (zh) * | 2004-04-12 | 2009-07-08 | 赵晓昂 | 舒痛方及其制剂和用途 |
| CN100548332C (zh) * | 2005-05-26 | 2009-10-14 | 赵晓昂 | 复方栀豉甘总提取物及其制剂和用途 |
| KR20080059430A (ko) | 2005-10-06 | 2008-06-27 | 나스텍 파마수티컬 컴퍼니 인코포레이티드 | 부갑상선 호르몬 제형 및 그 사용 방법 |
| WO2007066841A1 (en) | 2005-12-09 | 2007-06-14 | Serombio Co., Ltd. | Yeast hydrolysate containing cyclo-his-pro and method for producing the same |
| CN101125201A (zh) | 2006-08-17 | 2008-02-20 | 石家庄欧意药业有限公司 | 治疗骨质疏松症或防治由于骨质疏松而导致的骨折的药物组合物及其应用 |
| CN101674842A (zh) * | 2007-03-02 | 2010-03-17 | 普瑞芬医药有限公司 | 治疗阿尔茨海默氏病和痴呆的组合物和方法 |
| KR100989174B1 (ko) | 2010-02-01 | 2010-10-20 | (주)새롬바이오 | 여성 갱년기 증상개선에 효과를 갖는 효모 가수분해물 및 이를 포함하는 식품 |
| KR101138714B1 (ko) | 2011-07-26 | 2012-04-24 | (주)새롬바이오 | 효모 가수분해물을 유효성분으로 포함하는 연골세포 손상방지 및 재생효과를 갖는 조성물 |
| CN104971086B (zh) * | 2014-04-09 | 2020-12-08 | 台北医学大学 | 兔尾草于促进骨生成或提供神经保护之用途 |
| KR102012554B1 (ko) | 2016-07-13 | 2019-08-23 | 주식회사 노브메타파마 | 사이클로 히스티딘-프롤린을 유효성분으로 포함하는 세포 보호용 조성물 |
-
2018
- 2018-11-20 JP JP2020527807A patent/JP6944221B2/ja active Active
- 2018-11-20 EP EP18879826.8A patent/EP3714885B1/en active Active
- 2018-11-20 US US16/764,913 patent/US11975041B2/en active Active
- 2018-11-20 KR KR1020180143641A patent/KR102163445B1/ko active Active
- 2018-11-20 WO PCT/KR2018/014275 patent/WO2019098811A2/ko not_active Ceased
- 2018-11-20 CN CN201880074979.3A patent/CN111372586B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021503483A5 (enExample) | ||
| WO2016065226A8 (en) | Indole carboxamides compounds useful as kinase inhibitors | |
| FI3504187T3 (fi) | Pridopidiinin käyttö toiminnallisen heikkenemisen hoitoa varten | |
| MY197262A (en) | 1,3,4-oxadiazole sulfonamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same | |
| JP2017506624A5 (enExample) | ||
| PH12017501939A1 (en) | 1,3,4-oxadiazole sulfamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same | |
| MY197738A (en) | 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same | |
| JP2014198723A5 (enExample) | ||
| JP2017105861A5 (enExample) | ||
| RU2011134499A (ru) | Композиция 4-амино-2-(2,6-диоксопиперидин-3-ил)изоиндолин-1,3-диона | |
| JP2018513107A5 (enExample) | ||
| MX354423B (es) | Formulaciones de rasagilina de liberación prolongada y usos de las mismas. | |
| WO2017083304A8 (en) | Therapeutic compositions for treatment of human immunodeficiency virus | |
| JP2015038149A5 (enExample) | ||
| JP2017165776A5 (enExample) | ||
| JP2016510326A5 (enExample) | ||
| EA201492010A1 (ru) | Применение высокой дозы лахинимода для лечения рассеянного склероза | |
| JP2015038135A5 (enExample) | ||
| JP2015524444A5 (enExample) | ||
| JP2017222722A5 (enExample) | ||
| MX383665B (es) | Composiciones de donepezilo y métodos para tratar la enfermedad de alzheimer. | |
| JP2017105862A5 (enExample) | ||
| JP2017105859A5 (enExample) | ||
| ME02474B (me) | Terapijski režimi | |
| EP3424512A4 (en) | USE OF ALGIN SULFATE IN THE MANUFACTURE OF MEDICAMENTS AND HEALTH CARE PRODUCTS FOR THE PREVENTION AND TREATMENT OF ILLNESSES DUE TO HUMAN PAPILLOMA VIRUSES |